Abstract

Test methods to assess the skin sensitization potential of a substance usually use threshold criteria to dichotomize continuous experimental read-outs into yes/no conclusions. The threshold criteria are prescribed in the respective OECD test guidelines and the conclusion is used for regulatory hazard assessment, i.e., classification and labelling of the substance. We can identify a borderline range (BR) around the classification threshold within which test results are inconclusive due to a test method's biological and technical variability. We quantified BRs in the prediction models of the non-animal test methods DPRA, LuSens and h-CLAT, and of the animal test LLNA, respectively. Depending on the size of the BR, we found that between 6% and 28% of the substances in the sets tested with these methods were considered borderline. When the results of individual non-animal test methods were combined into integrated testing strategies (ITS), borderline test results of individual tests also affected the overall assessment of the skin sensitization potential of the testing strategy. This was analyzed for the 2-out-of-3 ITS: Four out of 40 substances (10%) were considered borderline. Based on our findings we propose expanding the standard binary classification of substances into "positive"/"negative" or "hazardous"/"non-hazardous" by adding a "borderline" or "inconclusive" alert for cases where test results fall within the borderline range.

Highlights

  • Skin sensitizers are substances that can lead to an allergic response following skin contact (UNECE, 2011)

  • If a substance is tested with any of the test methods shown in Table 2, and if the result falls within the borderline range (BR) of its prediction model, a clear-cut conclusion about the substance’s response in this test method is not possible with sufficient confidence

  • Technical and biological variability of non-animal test methods used for assessing skin sensitization potential, and the animal test local lymph node assay (LLNA), influence the precision of these methods

Read more

Summary

Introduction

Skin sensitizers are substances that can lead to an allergic response following skin contact (UNECE, 2011). An individual may be sensitized upon first contact. It is estimated that ACD affects about 20% of the European and North American population at least once in their lifetime, there is considerable variation of skin sensitization prevalence between different age-sex groups (Thyssen et al, 2007). Data on skin sensitization potential have to be provided for all substances produced or manufactured above one ton per year under the European chemicals legislation REACH, and for classification and labelling of substances under the European CLP regulation (ECHA, 2016). The assessment of a substance’s skin sensitization potential has been traditionally based on data derived from animal tests, such as the guinea pig based tests described in OECD TG 406 (OECD, 1992) or the murine local lymph node assay (LLNA) described in OECD TG 429 (OECD, 2002, 2010)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call